Anticoagulants Market Size By Drug Class (Factor Xa Inhibitors, Heparin, Warfarin, Direct Thrombin Inhibitors), By Route of Administration (Oral, Injectables), By Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Mar 2021  |  Report ID: GMI4967  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 150   |   Base Year: 2020




Report Content

Chapter 1.  Methodology

1.1. Market definitions

1.2. Base estimates & working

1.2.1.  North America

1.2.2.  Europe

1.2.3.  Asia Pacific

1.2.4.  Latin America

1.2.5.  Middle East & Africa

1.3. Forecast parameters

1.4. Data validation

1.5. Data Sources

1.5.1.  Secondary

1.5.1.1.   Paid sources

1.5.1.2.    Unpaid sources

1.5.2.  Primary

Chapter 2.  Executive Summary

2.1. Anticoagulants industry 360° synopsis, 2016-2027

2.1.1.  Business trends

2.1.2.  Drug class trends

2.1.3.  Route of administration trends

2.1.4.  Application trends

2.1.5.  Distribution channel trends

2.1.6.  Regional trends

Chapter 3.  Anticoagulants Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2016 - 2027

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1. Growing prevalence of chronic disease

3.3.1.2.    Growing adoption of novel oral anticoagulants (NOACs)

3.3.1.3.    Rising geriatric population across the globe

3.3.2.  Industry pitfalls & challenges

3.3.2.1. High risk of side effects

3.3.2.2.    Stringent regulatory framework

3.4. Growth potential analysis

3.4.1.  By drug class

3.4.2.  By route of administration

3.4.3.  By application

3.4.4.  By distribution channel

3.5. COVID-19 impact analysis

3.6. Porter’s analysis

3.7. Competitive landscape

3.7.1.  Company matrix analysis, 2019

3.8. PESTEL analysis

Chapter 4.  Anticoagulants Market, By Drug Class

4.1. Key segment trends

4.2. Factor Xa inhibitor

4.2.1.  Market size, by region, 2016 - 2027 (USD Million)

4.3. Heparin

4.3.1.  Market size, by region, 2016 - 2027 (USD Million)

4.4. Warfarin

4.4.1.  Market size, by region, 2016 - 2027 (USD Million)

4.5. Direct thrombin inhibitor

4.5.1.  Market size, by region, 2016 - 2027 (USD Million)

4.6. Others

4.6.1.  Market size, by region, 2016 - 2027 (USD Million)

Chapter 5.  Anticoagulants Market, By Route of Administration

5.1. Key segment trends

5.2. Oral

5.2.1.  Market size, by region, 2016 - 2027 (USD Million)

5.3. Injectable

5.3.1.  Market size, by region, 2016 - 2027 (USD Million)

Chapter 6.  Anticoagulants Market, By Application

6.1. Key segment trends

6.2. Venous thromboembolism

6.2.1.  Market size, by region, 2016 - 2027 (USD Million)

6.3. Atrial fibrillation/flutter

6.3.1.  Market size, by region, 2016 - 2027 (USD Million)

6.4. Coronary artery disease

6.4.1.  Market size, by region, 2016 - 2027 (USD Million)

6.5. Others

6.5.1.   Market size, by region, 2016 - 2027 (USD Million)

Chapter 7.  Anticoagulants Market, By Distribution Channel 

7.1. Key segment trends

7.2. Hospital pharmacy

7.2.1.  Market size, by region, 2016 - 2027 (USD Million)

7.3. Retail pharmacy

7.3.1.  Market size, by region, 2016 - 2027 (USD Million)

7.4. Online pharmacy

7.4.1.  Market size, by region, 2016 - 2027 (USD Million)

Chapter 8.  Anticoagulants Market, By Region

8.1. Key regional trends

8.2. North America

8.2.1.  Market size, by country, 2016 - 2027 (USD Million)

8.2.2.  Market size, by drug class, 2016 - 2027 (USD Million)

8.2.3.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.2.4.  Market size, by application, 2016 - 2027 (USD Million)

8.2.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.2.6.  U.S.

8.2.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.2.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.2.6.3.    Market size, by application, 2016 - 2027 (USD Million)

8.2.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.2.7.  Canada

8.2.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.2.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.2.7.3.    Market size, by application, 2016 - 2027 (USD Million)

8.2.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.3. Europe        

8.3.1.  Market size, by country, 2016 - 2027 (USD Million)

8.3.2.  Market size, by drug class, 2016 - 2027 (USD Million)

8.3.3.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.3.4.  Market size, by application, 2016 - 2027 (USD Million)

8.3.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.3.6.  Germany

8.3.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.3.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.3.6.3.    Market size, by application, 2016 - 2027 (USD Million)

8.3.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.3.7.  UK

8.3.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.3.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.3.7.3.    Market size, by application, 2016 - 2027 (USD Million)

8.3.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.3.8.  France

8.3.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.3.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.3.8.3.    Market size, by application, 2016 - 2027 (USD Million)

8.3.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.3.9.  Italy

8.3.9.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.3.9.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.3.9.3.    Market size, by application, 2016 - 2027 (USD Million)

8.3.9.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.3.10. Spain

8.3.10.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.3.10.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.3.10.3.  Market size, by application, 2016 - 2027 (USD Million)

8.3.10.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.4. Asia Pacific

8.4.1.  Market size, by country, 2016 - 2027 (USD Million)

8.4.2.  Market size, by drug class, 2016 - 2027 (USD Million)

8.4.3.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.4.4.  Market size, by application, 2016 - 2027 (USD Million)

8.4.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.4.6.  Japan

8.4.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.4.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.4.6.3.    Market size, by application, 2016 - 2027 (USD Million)

8.4.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.4.7.  China

8.4.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.4.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.4.7.3.    Market size, by application, 2016 - 2027 (USD Million)

8.4.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.4.8.  India

8.4.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.4.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.4.8.3.    Market size, by application, 2016 - 2027 (USD Million)

8.4.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.4.9.  Australia

8.4.9.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.4.9.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.4.9.3.    Market size, by application, 2016 - 2027 (USD Million)

8.4.9.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.5. Latin America

8.5.1.  Market size, by country, 2016 - 2027 (USD Million)

8.5.2.  Market size, by drug class, 2016 - 2027 (USD Million)

8.5.3.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.5.4.  Market size, by application, 2016 - 2027 (USD Million)

8.5.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.5.6.  Brazil

8.5.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.5.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.5.6.3.    Market size, by application, 2016 - 2027 (USD Million)

8.5.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.5.7.  Mexico

8.5.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.5.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.5.7.3.    Market size, by application, 2016 - 2027 (USD Million)

8.5.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.5.8.  Argentina

8.5.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.5.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.5.8.3.    Market size, by application, 2016 - 2027 (USD Million)

8.5.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.6. MEA

8.6.1.  Market size, by country, 2016 - 2027 (USD Million)

8.6.2.  Market size, by drug class, 2016 - 2027 (USD Million)

8.6.3.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.6.4.  Market size, by application, 2016 - 2027 (USD Million)

8.6.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.6.6.  South Africa

8.6.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.6.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.6.6.3.    Market size, by application, 2016 - 2027 (USD Million)

8.6.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.6.7.  Saudi Arabia

8.6.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.6.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.6.7.3.    Market size, by application, 2016 - 2027 (USD Million)

8.6.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

8.6.8.  UAE

8.6.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)

8.6.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)

8.6.8.3.    Market size, by application, 2016 - 2027 (USD Million)

8.6.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)

Chapter 9.  Company Profiles

9.1. Competitive dashboard, 2019

9.2. Bristol-Myers Squibb Company

9.2.1.  Business overview

9.2.2.  Financial data

9.2.3.  Product landscape

9.2.4.  Strategic outlook

9.2.5.  SWOT analysis

9.3. Bayer AG

9.3.1.  Business overview

9.3.2.  Financial data

9.3.3.  Product landscape

9.3.4.  Strategic outlook

9.3.5.  SWOT analysis

9.4. Boehringer Ingelheim

9.4.1.   Business overview

9.4.2.  Financial data

9.4.3.  Product landscape

9.4.4.  Strategic outlook

9.4.5.  SWOT analysis

9.5. Johnson and Johnson

9.5.1.    Business overview

9.5.2.  Financial data

9.5.3.  Product landscape

9.5.4.  Strategic outlook

9.5.5.  SWOT analysis

9.6. DAIICHI SANKYO COMPANY

9.6.1.  Business overview

9.6.2.  Financial data

9.6.3.  Product landscape

9.6.4.  Strategic outlook

9.6.5.  SWOT analysis

9.7. Portola Pharmaceutical

9.7.1.  Business overview

9.7.2.  Financial data

9.7.3.  Product landscape

9.7.4.  Strategic outlook

9.7.5.  SWOT analysis

9.8. Amphastar

9.8.1.  Business overview

9.8.2.  Financial data

9.8.3.  Product landscape

9.8.4.  Strategic outlook

9.8.5.  SWOT analysis

9.9. Leo Pharma

9.9.1.  Business overview

9.9.2.  Financial data

9.9.3.  Product landscape

9.9.4.  Strategic outlook

9.9.5.  SWOT analysis

9.10.  United Therapeutics

9.10.1.  Business overview

9.10.2.    Financial data

9.10.3.    Product landscape

9.10.4.    Strategic outlook

9.10.5.    SWOT analysis

9.11.  Pfizer

9.11.1.  Business overview

9.11.2.    Financial data

9.11.3.    Product landscape

9.11.4.    Strategic outlook

9.11.5.    SWOT analysis

9.12.  Rovi

9.12.1.  Business overview

9.12.2.    Financial data

9.12.3.    Product landscape

9.12.4.    Strategic outlook

9.12.5.    SWOT analysis

9.13.  Sanofi

9.13.1.  Business overview

9.13.2.    Financial data

9.13.3.    Product landscape

9.13.4.    Strategic outlook

9.13.5.    SWOT analysis

9.14.  Shenzhen Hepalink

9.14.1.  Business overview

9.14.2.    Financial data

9.14.3.    Product landscape

9.14.4.    Strategic outlook

9.14.5.    SWOT analysis
 

Data Tables

TABLE 1    Anticoagulants industry 3600 synopsis, 2016 - 2027

TABLE 2    Global anticoagulants market, 2016 - 2020 (USD Million)

TABLE 3    Global anticoagulants market, 2021 - 2027 (USD Million)

TABLE 4    Global anticoagulants market, by drug class, 2016 - 2020 (USD Million)

TABLE 5    Global anticoagulants market, by drug class, 2021 - 2027 (USD Million)

TABLE 6    Global anticoagulants market, by route of administration, 2016 - 2020 (USD Million)

TABLE 7    Global anticoagulants market, by route of administration, 2021 - 2027 (USD Million)

TABLE 8    Global anticoagulants market, by application, 2016 - 2020 (USD Million)

TABLE 9    Global anticoagulants market, by application, 2021 - 2027 (USD Million)

TABLE 10    Global anticoagulants market, by distribution channel, 2016 - 2020 (USD Million)

TABLE 11    Global anticoagulants market, by distribution channel, 2021 - 2027 (USD Million)

TABLE 12    Global anticoagulants market, by region, 2016 - 2020 (USD Million)

TABLE 13    Global anticoagulants market, by region, 2021 - 2027 (USD Million)

TABLE 14    Industry impact forces

TABLE 15    Factor Xa inhibitors market size, by region, 2016 - 2020 (USD Million)

TABLE 16    Factor Xa inhibitors market size, by region, 2021 - 2027 (USD Million)

TABLE 17    Heparin market size, by region, 2016 - 2020 (USD Million)

TABLE 18    Heparin market size, by region, 2021 - 2027 (USD Million)

TABLE 19    Warfarin market size, by region, 2016 - 2020 (USD Million)

TABLE 20    Warfarin market size, by region, 2021 - 2027 (USD Million)

TABLE 21    Direct thrombin inhibitors market size, by region, 2016 - 2020 (USD Million)

TABLE 22    Direct thrombin inhibitors market size, by region, 2021 - 2027 (USD Million)

TABLE 23    Others market size, by region, 2016 - 2020 (USD Million)

TABLE 24    Others market size, by region, 2021 - 2027 (USD Million)

TABLE 25    Oral market size, by region, 2016 - 2020 (USD Million)

TABLE 26    Oral market size, by region, 2021 - 2027 (USD Million)

TABLE 27    Injectable market size, by region, 2016 - 2020 (USD Million)

TABLE 28    Injectable market size, by region, 2021 - 2027 (USD Million)

TABLE 29    Venous thromboembolism market size, by region, 2016 - 2020 (USD Million)

TABLE 30    Venous thromboembolism market size, by region, 2021 - 2027 (USD Million)

TABLE 31    Atrial fibrillation/flutter market size, by region, 2016 - 2020 (USD Million)

TABLE 32    Atrial fibrillation/flutter market size, by region, 2021 - 2027 (USD Million)

TABLE 33    Coronary artery disease market size, by region, 2016 - 2020 (USD Million)

TABLE 34    Coronary artery disease market size, by region, 2021 - 2027 (USD Million)

TABLE 35    Others market size, by region, 2016 - 2020 (USD Million)

TABLE 36    Others market size, by region, 2021 - 2027 (USD Million)

TABLE 37    Hospital pharmacy market size, by region, 2016 - 2020 (USD Million)

TABLE 38    Hospital pharmacy market size, by region, 2021 - 2027 (USD Million)

TABLE 39    Retail pharmacy market size, by region, 2016 - 2020 (USD Million)

TABLE 40    Retail pharmacy market size, by region, 2021 - 2027 (USD Million)

TABLE 41    Online pharmacy market size, by region, 2016 - 2020 (USD Million)

TABLE 42    Online pharmacy market size, by region, 2021 - 2027 (USD Million)

TABLE 43    North America anticoagulants market size, by country, 2016 - 2020 (USD Million)

TABLE 44    North America anticoagulants market size, by country, 2021 - 2027 (USD Million)

TABLE 45    North America anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 46    North America anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 47    North America anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 48    North America anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 49    North America anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 50    North America anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 51    North America anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 52    North America anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 53    U.S. anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 54    U.S. anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 55    U.S. anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 56    U.S. anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 57    U.S. anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 58    U.S. anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 59    U.S. anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 60    U.S. anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 61    Canada anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 62    Canada anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 63    Canada anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 64    Canada anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 65    Canada anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 66    Canada anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 67    Canada anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 68    Canada anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 69    Europe anticoagulants market size, by country, 2016 - 2020 (USD Million)

TABLE 70    Europe anticoagulants market size, by country, 2021 - 2027 (USD Million)

TABLE 71    Europe anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 72    Europe anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 73    Europe anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 74    Europe anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 75    Europe anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 76    Europe anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 77    Europe anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 78    Europe anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 79    Germany anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 80    Germany anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 81    Germany anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 82    Germany anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 83    Germany anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 84    Germany anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 85    Germany anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 86    Germany anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 87    UK anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 88    UK anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 89    UK anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 90    UK anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 91    UK anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 92    UK anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 93    UK anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 94    UK anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 95    France anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 96    France anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 97    France anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 98    France anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 99    France anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 100  France anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 101  France anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 102  France anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 103  Italy anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 104  Italy anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 105  Italy anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 106  Italy anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 107  Italy anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 108  Italy anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 109  Italy anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 110  Italy anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 111  Spain anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 112  Spain anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 113  Spain anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 114  Spain anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 115  Spain anticoagulants market size, by source, 2021 - 2027 (USD Million)

TABLE 116  Spain anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 117  Spain anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 118  Spain anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 119  Spain anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 120  Asia Pacific anticoagulants market size, by country, 2016 - 2020 (USD Million)

TABLE 121  Asia Pacific anticoagulants market size, by country, 2021 - 2027 (USD Million)

TABLE 122  Asia Pacific anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 123  Asia Pacific anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 124  Asia Pacific anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 125  Asia Pacific anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 126  Asia Pacific anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 127  Asia Pacific anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 128  Asia Pacific anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 129  Asia Pacific anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 130  China anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 131  China anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 132  China anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 133  China anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 134  China anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 135  China anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 136  China anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 137  China anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 138  Japan anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 139  Japan anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 140  Japan anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 141  Japan anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 142  Japan anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 143  Japan anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 144  Japan anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 145  Japan anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 146  India anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 147  India anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 148  India anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 149  India anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 150  India anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 151  India anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 152  India anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 153  India anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 154  Australia anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 155  Australia anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 156  Australia anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 157  Australia anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 158  Australia anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 159  Australia anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 160  Australia anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 161  Australia anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 162  Latin America anticoagulants market size, by country, 2016 - 2020 (USD Million)

TABLE 163  Latin America anticoagulants market size, by country, 2021 - 2027 (USD Million)

TABLE 164  Latin America anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 165  Latin America anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 166  Latin America anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 167  Latin America anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 168  Latin America anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 169  Latin America anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 170  Latin America anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 171  Latin America anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 172  Brazil anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 173  Brazil anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 174  Brazil anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 175  Brazil anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 176  Brazil anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 177  Brazil anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 178  Brazil anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 179  Brazil anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 180  Mexico anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 181  Mexico anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 182  Mexico anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 183  Mexico anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 184  Mexico anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 185  Mexico anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 186  Mexico anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 187  Mexico anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 188  Argentina anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 189  Argentina anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 190  Argentina anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 191  Argentina anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 192  Argentina anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 193  Argentina anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 194  Argentina anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 195  Argentina anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 196  MEA anticoagulants market size, by country, 2016 - 2020 (USD Million)

TABLE 197  MEA anticoagulants market size, by country, 2021 - 2027 (USD Million)

TABLE 198  MEA anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 199  MEA anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 200  MEA anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 201  MEA anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 202  MEA anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 203  MEA anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 204  MEA anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 205  MEA anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 206  South Africa anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 207  South Africa anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 208  South Africa anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 209  South Africa anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 210  South Africa anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 211  South Africa anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 212  South Africa anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 213  South Africa anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 214  Saudi Arabia anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 215  Saudi Arabia anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 216  Saudi Arabia anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 217  Saudi Arabia anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 218  Saudi Arabia anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 219  Saudi Arabia anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 220  Saudi Arabia anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 221  Saudi Arabia anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)

TABLE 222  UAE anticoagulants market size, by drug class, 2016 - 2020 (USD Million)

TABLE 223  UAE anticoagulants market size, by drug class, 2021 - 2027 (USD Million)

TABLE 224  UAE anticoagulants market size, by route of administration, 2016 - 2020 (USD Million)

TABLE 225  UAE anticoagulants market size, by route of administration, 2021 - 2027 (USD Million)

TABLE 226  UAE anticoagulants market size, by application, 2016 - 2020 (USD Million)

TABLE 227  UAE anticoagulants market size, by application, 2021 - 2027 (USD Million)

TABLE 228  UAE anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million)

TABLE 229  UAE anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million)
 

Charts & Figures

FIG. 1   Top-down approach

FIG. 2   Breakdown of primary participants

FIG. 3   Anticoagulants industry 3600 synopsis

FIG. 4   Industry segmentation

FIG. 5   Global anticoagulants market, 2016 - 2027 (USD Million)

FIG. 6   Growth potential analysis, by drug class

FIG. 7   Growth potential analysis, by route of administration

FIG. 8   Growth potential analysis, by application

FIG. 9   Growth potential analysis, by distribution channel

FIG. 10 Porter’s analysis

FIG. 11 Company matrix analysis, 2019

FIG. 12 PESTEL analysis

FIG. 13 Key segment trends, by drug class

FIG. 14 Key segment trends, by route of administration

FIG. 15 Key segment trends, by application

FIG. 16 Key segment trends, by distribution channel

FIG. 17 Key regional trends

FIG. 18 Competitive dashboard, 2019
 

Premium Report Details

  • Published Date: Mar 2021
  • Pages: 150
  • Tables: 229
  • Charts / Figures: 18
  • Companies covered: 13

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X